Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03118544 · ClinicalTrials.gov registry record
REduction of Contrast Via DyeVert Used in CTO Procedures
A clinical trial, sponsored by Minneapolis Heart Institute Foundation.
- Terminated
- Registry status
- 21
- Enrollment target
NCT03118544: Clinical Trial study, sponsored by Minneapolis Heart Institute Foundation.
NCT03118544 is a clinical trial that was terminated before completion, run by Minneapolis Heart Institute Foundation. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03118544 was terminated before completion, sponsored by Minneapolis Heart Institute Foundation.
- TERMINATED
- Registry status
- 21 participants
- Enrollment target
Study Summary
The is an observational, prospective study to evaluate the effect of the DyeVert System on contrast volume administration in patients undergoing clinically-indicated chronic total occlusion (CTO) percutaneous coronary intervention (PCI)
Primary Outcome
The hypothesis of the study is that use of the DyeVert System will result in lower contrast volume, determined through real-time monitoring with the DyeVert System.
Interventions
- DEVICE DyeVert System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2017-03-26 |
| Est. Completion | 2018-02-02 |
Why NCT03118544 stopped before completion
NCT03118544 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which DyeVert System is the first listed.
NCT03118544 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03118544 about?
NCT03118544 is a clinical study titled "REduction of Contrast Via DyeVert Used in CTO Procedures". The is an observational, prospective study to evaluate the effect of the DyeVert System on contrast volume administration in patients undergoing clinically-indicated chronic total occlusion (CTO) percutaneous coronary intervention (PCI)
What is the current status of trial NCT03118544?
This trial is currently terminated. The enrollment target is 21 participants. The study started on 2017-03-26. Estimated completion is 2018-02-02.
What interventions are being tested in trial NCT03118544?
The interventions under investigation include: DyeVert System (DEVICE).
Who is sponsoring clinical trial NCT03118544?
This trial is sponsored by Minneapolis Heart Institute Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI